Recently, the concept of traditional Chinese medicine has continued to heat up on the Internet, attracting the attention of a large number of netizens. However, in the A** market, there are not many Chinese medicine stocks with real long-term investment value, only ten. For other so-called "Chinese medicine stocks", investors should remain vigilant and choose carefully.
So, what are the characteristics of traditional Chinese medicine stocks that have the potential to be bullish in the long term? The key lies in two points. First of all, investors should choose those TCM stocks that are favored by institutional investors. The pharmaceutical industry is difficult to study and difficult for ordinary investors to understand in depth. However, if you keep up with the pace of professional institutions, you will be able to grasp market opportunities. Institutional investors have a wealth of experience and a professional team, and they have a much better understanding of the pharmaceutical industry than ordinary investors. As a result, their choices often reflect the true value of TCM stocks.
Second, investors should pay attention to TCM stocks with higher gross margins. Historically, the company generally has a gross profit margin of more than 50%, such as Hengrui Pharmaceutical, Pien Tze Huang and other star stocks, whose gross profit margins are more than 50%. Therefore, investors must pay attention to these two core criteria when choosing Chinese medicine stocks. Only Chinese medicine stocks that meet these conditions have the potential to be bullish in the long term. Through the screening of these two criteria, investors can more accurately grasp the market trend and select Chinese medicine stocks with investment value.
Based on the above two points, there are only ten Chinese medicine stocks worth paying attention to in the whole A** market. In particular, it is worth mentioning the last company, whose products have been proven to have a significant effect on the new crown, and have recently received a collective increase in positions from many institutions. So, what exactly are these ten Chinese medicine stocks? Let's find out.
The tenth Zhongsheng PharmaceuticalThe gross profit margin is 66%, and the top ten shareholders include social security**, Hong Kong** settlement, Ruifeng No. 1**,The ninth Zhongheng GroupThe gross profit margin is 72%, and among the top ten shareholders are **Huijin, Boshi CSI, E Fund CSI,The eighth Kangyuan Pharmaceutical, gross profit margin of 75% among the top ten shareholders are Gao Yi,**Dr. Huijin**,The seventh house has 100 pills, gross profit margin of 78%, among the top ten shareholders are Jin Yuan Shun'an**, Société Générale JPMorgan Chase and so onThe sixth Lingrui Pharmaceutical, gross profit margin of 3% Among the top ten shareholders are Gaoyi Capital, GF Steady Growth**, and two pensions**,The remaining five are even more powerful, one of the company's products has been hammered, and it can be the first new crown, and many institutions have collectively increased their positions in the near future.
I only leave these companies to iron fansInterested friends can click on my avatar, enter the homepage background and send me the number 178, remember that it is not the comment area, and the answer will be displayed automatically, I solemnly promise that all sharing is free, everyone can rest assured to check it, even if it is beneficial to you to make a reference.